IS7827A - Ný efnasambönd - Google Patents
Ný efnasamböndInfo
- Publication number
- IS7827A IS7827A IS7827A IS7827A IS7827A IS 7827 A IS7827 A IS 7827A IS 7827 A IS7827 A IS 7827A IS 7827 A IS7827 A IS 7827A IS 7827 A IS7827 A IS 7827A
- Authority
- IS
- Iceland
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203070A SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Novel compounds |
PCT/SE2003/001604 WO2004035548A1 (en) | 2002-10-16 | 2003-10-15 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7827A true IS7827A (is) | 2005-04-27 |
Family
ID=20289294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7827A IS7827A (is) | 2002-10-16 | 2005-04-27 | Ný efnasambönd |
Country Status (20)
Country | Link |
---|---|
US (1) | US7407968B2 (is) |
EP (1) | EP1554254A1 (is) |
JP (1) | JP2006505568A (is) |
KR (1) | KR20050049551A (is) |
CN (1) | CN100349874C (is) |
AR (1) | AR041626A1 (is) |
AU (1) | AU2003269775B2 (is) |
BR (1) | BR0315320A (is) |
CA (1) | CA2501418A1 (is) |
IS (1) | IS7827A (is) |
MX (1) | MXPA05003901A (is) |
NO (1) | NO20052182L (is) |
NZ (1) | NZ539079A (is) |
PL (1) | PL376564A1 (is) |
RU (1) | RU2323211C2 (is) |
SE (1) | SE0203070D0 (is) |
TW (1) | TWI285638B (is) |
UA (1) | UA81919C2 (is) |
WO (1) | WO2004035548A1 (is) |
ZA (1) | ZA200502928B (is) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
SE0301701D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0301698D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0301699D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
DE602005011844D1 (de) * | 2004-11-02 | 2009-01-29 | Pfizer | Sulfonylbenzimidazolderivate |
WO2007091950A1 (en) * | 2006-02-07 | 2007-08-16 | Astrazeneca Ab | Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain |
CN101511796B (zh) | 2006-09-05 | 2012-05-09 | 协和发酵麒麟株式会社 | 咪唑衍生物 |
WO2008032764A1 (fr) | 2006-09-13 | 2008-03-20 | Kyowa Hakko Kirin Co., Ltd. | Dérivé hétérocyclique fusionné |
JP5485148B2 (ja) * | 2007-06-21 | 2014-05-07 | カラ セラピューティクス インコーポレイテッド | 置換イミダゾ複素環 |
WO2009025785A2 (en) * | 2007-08-21 | 2009-02-26 | Merck & Co., Inc. | Cb2 receptor ligands for the treatment of pain |
KR101837759B1 (ko) | 2010-02-18 | 2018-04-26 | 브이티브이 테라퓨틱스 엘엘씨 | 치환된 융합 이미다졸 유도체, 약학적 조성물, 및 그것의 사용 방법 |
US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
AU2012284184B2 (en) | 2011-07-18 | 2017-03-09 | Merck Patent Gmbh | Benzamides |
US10835521B2 (en) * | 2012-07-13 | 2020-11-17 | The Cleveland Clinic Foundation | Neuroprotective CB2 receptor agonists |
WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
CN111658644B (zh) * | 2020-03-31 | 2021-05-14 | 中山大学 | 一种小分子stat3抑制剂wz-2-033及其在制备治疗乳腺癌和胃癌药物中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2945044A (en) * | 1957-07-12 | 1960-07-12 | Ciba Pharm Prod Inc | Certain 1-(diethyl-aminoethyl), 5-amino, 2-benzyl or substituted benzyl, benzimidazoles |
FR1481049A (fr) * | 1965-11-25 | 1967-05-19 | France Ministre Des Armees | Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués |
CA2036307C (en) | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
CA2436133A1 (en) * | 2001-01-29 | 2002-08-08 | University Of Connecticut | Receptor selective cannabimimetic aminoalkylindoles |
SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
AU2002347022A1 (en) * | 2001-12-20 | 2003-07-09 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
-
2002
- 2002-10-16 SE SE0203070A patent/SE0203070D0/xx unknown
-
2003
- 2003-10-09 TW TW092128115A patent/TWI285638B/zh not_active IP Right Cessation
- 2003-10-15 CN CNB2003801059214A patent/CN100349874C/zh not_active Expired - Fee Related
- 2003-10-15 AU AU2003269775A patent/AU2003269775B2/en not_active Ceased
- 2003-10-15 PL PL376564A patent/PL376564A1/pl not_active Application Discontinuation
- 2003-10-15 RU RU2005109156/04A patent/RU2323211C2/ru not_active IP Right Cessation
- 2003-10-15 MX MXPA05003901A patent/MXPA05003901A/es not_active Application Discontinuation
- 2003-10-15 JP JP2004545139A patent/JP2006505568A/ja active Pending
- 2003-10-15 US US10/530,499 patent/US7407968B2/en not_active Expired - Fee Related
- 2003-10-15 UA UAA200502658A patent/UA81919C2/uk unknown
- 2003-10-15 AR ARP030103753A patent/AR041626A1/es unknown
- 2003-10-15 WO PCT/SE2003/001604 patent/WO2004035548A1/en active IP Right Grant
- 2003-10-15 CA CA002501418A patent/CA2501418A1/en not_active Abandoned
- 2003-10-15 BR BR0315320-7A patent/BR0315320A/pt not_active IP Right Cessation
- 2003-10-15 EP EP03751705A patent/EP1554254A1/en not_active Withdrawn
- 2003-10-15 KR KR1020057006538A patent/KR20050049551A/ko not_active Application Discontinuation
- 2003-10-15 NZ NZ539079A patent/NZ539079A/en unknown
-
2005
- 2005-04-11 ZA ZA200502928A patent/ZA200502928B/en unknown
- 2005-04-27 IS IS7827A patent/IS7827A/is unknown
- 2005-05-03 NO NO20052182A patent/NO20052182L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2323211C2 (ru) | 2008-04-27 |
WO2004035548A1 (en) | 2004-04-29 |
US20070105893A1 (en) | 2007-05-10 |
AU2003269775A1 (en) | 2004-05-04 |
JP2006505568A (ja) | 2006-02-16 |
MXPA05003901A (es) | 2005-06-22 |
TW200410944A (en) | 2004-07-01 |
ZA200502928B (en) | 2006-02-22 |
CA2501418A1 (en) | 2004-04-29 |
CN1726194A (zh) | 2006-01-25 |
SE0203070D0 (en) | 2002-10-16 |
TWI285638B (en) | 2007-08-21 |
UA81919C2 (uk) | 2008-02-25 |
KR20050049551A (ko) | 2005-05-25 |
RU2005109156A (ru) | 2006-01-20 |
US7407968B2 (en) | 2008-08-05 |
AU2003269775B2 (en) | 2007-05-03 |
EP1554254A1 (en) | 2005-07-20 |
BR0315320A (pt) | 2005-08-16 |
NO20052182L (no) | 2005-05-03 |
AR041626A1 (es) | 2005-05-26 |
CN100349874C (zh) | 2007-11-21 |
NZ539079A (en) | 2007-11-30 |
PL376564A1 (pl) | 2006-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7471A (is) | Ný efnasambönd | |
IS7879A (is) | Ný efnasambönd | |
ATE368042T1 (de) | Cephemverbindungen | |
IS8108A (is) | Ný efnasambönd | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS7381A (is) | Efnasambönd | |
NO20044046L (no) | Substituerte hydroksyetylaminer | |
IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
IS8292A (is) | Ný efnasambönd | |
NO20045659L (no) | Forbindelser | |
IS7793A (is) | Nýtt efnasamband | |
IS7827A (is) | Ný efnasambönd | |
IS7794A (is) | Nýtt efnasamband | |
ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
IS8089A (is) | Efnasambönd | |
NO20031736D0 (no) | Forbindelser | |
ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
SE0303452D0 (sv) | New compounds | |
ITMI20021329A1 (it) | Nuove ossialchilammine sostituite | |
DE50306228D1 (de) | Substituierte benzdioxepine | |
SE0203348D0 (sv) | Novel compounds | |
SE0202181D0 (sv) | New compounds | |
SE0203751D0 (sv) | New Compounds | |
SE0203122D0 (sv) | New Compounds |